08. 09. 2009.
The next large state privatization to be announced in Serbia will be that of the pharmaceutical company Galenika. The Minister of Economy has placed a minimum price for 70% of the company at EUR 200 million. Germany’s Stad Arzneimittel AG, which owns Hemofarm in Vrsac, and Greece’s Alapis are seen as the most serious contenders for the tender.